Details for New Drug Application (NDA): 089099
✉ Email this page to a colleague
NDA 089099 describes BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, which is a drug marketed by Abraxis Pharm and Hospira and is included in three NDAs. It is available from four suppliers. Additional details are available on the BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER profile page.
The generic ingredient in BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER is sterile water for injection. There are one thousand and seventy-two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.
The generic ingredient in BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER is sterile water for injection. There are one thousand and seventy-two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.
Summary for 089099
| Tradename: | BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER |
| Applicant: | Abraxis Pharm |
| Ingredient: | sterile water for injection |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LIQUID;N/A | Strength | 100% | ||||
| Approval Date: | Dec 29, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
